CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES

CENTRAL BRAIN TUMOR REGISTRY OF THE UNITED STATES specializes in the collection, management, and analysis of national cancer registry data to support public health surveillance and research. Their core capabilities center on secure computing infrastructure for large-scale biomedical data processing, including web-hosted data repositories, standardized data ingestion pipelines, and secure storage systems compliant with federal health information protocols. They deliver specialized data processing services tailored to malignant and non-malignant tumor registries, enabling longitudinal tracking, statistical analysis, and reporting for epidemiological studies. Their technical expertise includes data normalization, metadata management, and secure data exchange frameworks designed for sensitive health information, with a focus on maintaining data integrity and accessibility for public health stakeholders. The contractor has demonstrated consistent engagement with the Department of Health and Human Services, delivering critical data infrastructure and processing services that support national cancer surveillance initiatives. Their work directly enables HHS agencies to monitor tumor incidence, track outcomes, and inform policy through authoritative, standardized datasets. This relationship reflects a sustained partnership grounded in mission-critical public health reporting requirements. Their primary industry focus is in computing infrastructure and data processing services under NAICS 518210, positioning them as a niche provider of specialized health data systems rather than general IT services. They serve the public health and biomedical research vertical, offering tailored solutions for cancer registry operations that require high accuracy, regulatory alignment, and long-term data stewardship. The entity is headquartered in Pewaukee, Wisconsin, and operates as a non-profit organization under the 8H classification. While no formal government certifications are listed, their work is inherently aligned with federal health data standards and privacy requirements. Their market positioning is defined by domain-specific expertise in neuro-oncology and cancer registry systems, serving as a trusted steward of national cancer data for public health decision-making.